TG Therapeutics | Ativos





Ativos Alterar Data
AbbVie USD 133.9B 3.28B 2025-09
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
Amgen USD 90.14B 2.24B 2025-09
Ardelyx USD 486.17M 19.4M 2025-09
Arrowhead Research USD 1.6B 218.89M 2025-12
Bayer EUR 104.21B 1.03B 2025-09
Biogen USD 29.21B 877.3M 2025-09
Corcept Therapeutics USD 823.61M 21.88M 2025-09
Dynavax Technologies USD 946.51M 28.06M 2025-09
Gilead Sciences USD 58.53B 2.81B 2025-09
J&J USD 192.82B 573M 2025-09
Novartis USD 107.29B 2.89B 2025-09
PTC Therapeutics USD 2.64B 9.54M 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
TG Therapeutics USD 1.03B 322.41M 2025-09
Vertex Pharmaceuticals USD 24.86B 825.6M 2025-09


TG Therapeutics Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.